1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA [2] Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA [3] Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA.
1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA [2] BBS Program, Harvard Medical School, Boston, Massachusetts 02115, USA.
Nature. 2014 Oct 2;514(7520):54-8. doi: 10.1038/nature13556. Epub 2014 Jul 30.
Cancers arise through a process of somatic evolution that can result in substantial sub-clonal heterogeneity within tumours. The mechanisms responsible for the coexistence of distinct sub-clones and the biological consequences of this coexistence remain poorly understood. Here we used a mouse xenograft model to investigate the impact of sub-clonal heterogeneity on tumour phenotypes and the competitive expansion of individual clones. We found that tumour growth can be driven by a minor cell subpopulation, which enhances the proliferation of all cells within a tumour by overcoming environmental constraints and yet can be outcompeted by faster proliferating competitors, resulting in tumour collapse. We developed a mathematical modelling framework to identify the rules underlying the generation of intra-tumour clonal heterogeneity. We found that non-cell-autonomous driving of tumour growth, together with clonal interference, stabilizes sub-clonal heterogeneity, thereby enabling inter-clonal interactions that can lead to new phenotypic traits.
癌症是通过体细胞进化过程产生的,这可能导致肿瘤内存在大量亚克隆异质性。导致不同亚克隆共存的机制以及这种共存的生物学后果仍知之甚少。在这里,我们使用小鼠异种移植模型来研究亚克隆异质性对肿瘤表型和单个克隆竞争扩展的影响。我们发现,肿瘤生长可以由一小部分细胞亚群驱动,这些细胞通过克服环境限制来增强肿瘤内所有细胞的增殖,然而,它们可能会被增殖更快的竞争者所淘汰,从而导致肿瘤崩溃。我们开发了一个数学建模框架来确定肿瘤内克隆异质性产生的规则。我们发现,肿瘤生长的非细胞自主驱动,加上克隆干扰,稳定了亚克隆异质性,从而使克隆间相互作用成为可能,从而产生新的表型特征。